Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271931 · ClinicalTrials.gov registry record · NA
Active Choice in the EHR to Promote Statin Therapy
A NA study of Cardiovascular Diseases, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 23,066
- Enrollment target
- 1
- Study location
NCT03271931: Completed NA study of Cardiovascular Diseases, sponsored by University of Pennsylvania.
NCT03271931 is a NA study of Cardiovascular Diseases that has completed, run by University of Pennsylvania. The registered enrollment target is 23,066 participants, below the 26,897-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03271931, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 23,066 participants
- Enrollment target
- 1
- Study location
Study Summary
Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often either not prescribed or under-prescribed for patients that meet evidence-based guidelines. In this study, we will evaluate a health system initiative using active and passive choice prompts in the electronic health record to prompt cardiologists to prescribe evidence-based statin therapy. In partnership with the health system, this will be conducted as a randomized, controlled trial to evaluate its effect.
Primary Outcome
Among patients not on guideline-based statin dosages, the percent that are prescribed guideline-based therapy at appropriate dose.
Conditions Studied
Interventions
- BEHAVIORAL Active choice
- BEHAVIORAL Passive choice
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23,066 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2019-06-05 |
| Phase | NA |
What the finished NCT03271931 record still lists
NCT03271931 is an interventional study that assigns participants to a tested intervention. Its 23,066 participants enrollment target places it among the larger protocols in the corpus, below the 26,897-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Active choice is the first listed.
NCT03271931 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03271931 about?
NCT03271931 is a clinical study titled "Active Choice in the EHR to Promote Statin Therapy". Cardiovascular (CV) events are the leading cause of mortality in the United States. Statins have been demonstrated to be an effective tool for reducing CV events and mortality, but statins are often either not prescribed or under-prescribed for patients that meet evidence-based guidelines. In this s...
What is the current status of trial NCT03271931?
This trial is currently completed. It is a NA study. The enrollment target is 23,066 participants. The study started on 2018-09-24. Estimated completion is 2019-06-05.
What conditions does trial NCT03271931 study?
This clinical trial studies the following conditions: Cardiovascular Diseases.
What interventions are being tested in trial NCT03271931?
The interventions under investigation include: Active choice (BEHAVIORAL), Passive choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT03271931?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03271931 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03271931's enrollment target sits among peer trials
23,066 8th of 300 higher than 293 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06486688 · 22,320 participants · NA
Centralized Virtual SBIRT for Pediatric Primary Care
- NCT06995898 · 24,000 participants · NA
The Vanguard Study: Testing a New Way to Screen for Cancer
- NCT07413211 · 22,068 participants
Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness
- NCT05488080 · 22,032 participants · NA
PAINED: Project Addressing INequities in the Emergency Department
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI